Loading…

BCL2 gene abnormalities define distinct clinical subsets of follicular lymphoma

Aims:  Follicular lymphoma (FL) arising primarily in the skin has recently been proposed as a distinct entity on the basis of a low incidence of t(14;18)(q32;q21) and bcl‐2 expression, with a very high percentage of patients surviving more than 5 years. However, cases of t(14;18)(q32;q21)‐positive p...

Full description

Saved in:
Bibliographic Details
Published in:Histopathology 2006-09, Vol.49 (3), p.229-241
Main Authors: Goodlad, J R, Batstone, P J, Hamilton, D A, Kernohan, N M, Levison, D A, White, J M
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aims:  Follicular lymphoma (FL) arising primarily in the skin has recently been proposed as a distinct entity on the basis of a low incidence of t(14;18)(q32;q21) and bcl‐2 expression, with a very high percentage of patients surviving more than 5 years. However, cases of t(14;18)(q32;q21)‐positive primary cutaneous FL (PCFL) and examples of t(14;18)(q32;q21)‐negative FL at nodal and other extranodal sites, are well documented. The aim of this study was to test the hypothesis that there is a subtype of FL lacking t(14;18)(q32;q21), which preferentially involves certain sites but is not restricted by anatomical location. Methods and results:  A cohort of 47 stage 1 FL was stratified according to the presence or absence of t(14;18)(q32;q21) using conventional cytogenetics, polymerase chain reaction and interphase fluorescence in situ hybridization. Compared with t(14;18)(q32;q21)‐positive cases, FL lacking the translocation were less likely to express CD10 or bcl‐2 (P 
ISSN:0309-0167
1365-2559
DOI:10.1111/j.1365-2559.2006.02501.x